Cours Regenicin Inc OTC Bulletin Board
Actions
US75887Q1022
Recherche biotechnologique et médicale
Cours en clôture
Autres places de cotation
|
||
- USD | - |
|
CA 2021 | - | CA 2022 | - | Capitalisation | 491 k 441 k |
---|---|---|---|---|---|
Résultat net 2021 | - 0 | Résultat net 2022 | - 0 | VE / CA 2021 | - |
Dette nette 2021 | 598 k 538 k | Dette nette 2022 | 627 k 564 k | VE / CA 2022 | - |
PER 2021 |
-2
x | PER 2022 |
-0,71
x | Employés | - |
Rendement 2021 * |
-
| Rendement 2022 |
-
| Flottant | 79,1% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Randall McCoy
CEO | Chief Executive Officer | 74 | 15/07/10 |
John Weber
DFI | Director of Finance/CFO | 74 | 13/09/10 |
J. Nelson
CTO | Chief Tech/Sci/R&D Officer | 75 | 15/07/10 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
John Weber
DFI | Director of Finance/CFO | 74 | 13/09/10 |
Randall McCoy
CEO | Chief Executive Officer | 74 | 15/07/10 |
Varia. 1 janv. | Capi. | |
---|---|---|
+16,13% | 122 Md | |
+19,65% | 115 Md | |
+21,22% | 26,64 Md | |
-23,84% | 19,91 Md | |
-17,47% | 16,32 Md | |
-45,95% | 15,52 Md | |
-19,28% | 15,49 Md | |
+63,81% | 14,83 Md | |
+1,94% | 13,67 Md |
- Bourse
- Actions
- Action RGIN
- Action